Administration of Kisspeptin in Patients With Hyperprolactinemia

Summary

The goal of this study is to learn more about how kisspeptin, a naturally occurring hormone, affects women with high levels of prolactin (also called hyperprolactinemia). Subjects in one group will undergo blood sampling every 10 minutes over two 12-hour periods (one 12-hour period without any intervention and one 12-hour period with intravenous (IV) kisspeptin administration). Subjects in the second group will receive subcutaneous (SC) kisspeptin every 90 minutes for eight days.

Timeline

Start

2017-11-17

Primary completion

2023-06-28

Completion

2023-07-29

Drugs

Indications